Primary Sclerosing Cholangitis clinical trials at UCSF

2 in progress, 1 open to eligible people

Primary sclerosing cholangitis is a rare liver disease that causes damage and scarring in bile ducts. UCSF is conducting an observational study that records patient experiences from routine clinical care. UCSF is compiling these records into a data set to help compare outcomes across groups.

Showing trials for

  • Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)

    open to eligible people ages 18-75

    Develop an appropriate real-world data comparator cohort to support the design, execution, and serve as an external control for interventional clinical trials in PSC.

    San Francisco, California and other locations

  • Liver Cirrhosis Network Cohort Study

    Sorry, in progress, not accepting new patients

    Liver Cirrhosis Network (LCN) Cohort Study is an observational study designed to identify risk factors and develop prediction models for risk of decompensation in adults with liver cirrhosis. LCN Cohort Study involves multiple institutions and an anticipated 1200 participants. Enrolled participants will have study visits every 6 months (180 days), with opportunities to complete specific visit components via telehealth or remotely. Visits will include collection of questionnaire data and the in-person visits will include questionnaires, physical exams, imaging, and sample collection.

    San Francisco, California and other locations

Our lead scientists for Primary Sclerosing Cholangitis research studies include .

Last updated: